From scientific project to structured project : the right questions to ask before moving forward

In the healthcare sector, the transition from a scientific project to a structured project is one of the most critical moments in the innovation journey. It is a pivotal phase, often experienced as a push to “accelerate” — quickly transforming an intuition or a research breakthrough into a concrete, visible, and fundable solution.
Yet, accelerating too soon is one of the most common — and most costly — pitfalls.

Clarify before accelerating: a step too often overlooked

Pressure can come from all sides: funding opportunities, institutional expectations, potential partners, and internal team dynamics. In this context, it’s tempting to skip certain steps, assuming that adjustments can be made later.

But in healthcare innovation, what goes unaddressed early on never disappears. It simply shifts — and often resurfaces at the most critical moment.

Before accelerating the process, certain questions deserve to be asked clearly:

• What is the project’s actual level of maturity, beyond its scientific value?
• What are the regulatory, technical, or organizational constraints in the short and medium term?
• Are current resources aligned with the stated ambitions?
• Does the framework truly support the next phase of the project?

Taking the time to address these questions is not a hindrance. It is a strategic move.

Structuring without compromising the scientific process

Structuring a project does not mean prematurely turning it into a business venture, nor does it mean locking it into a rigid framework. This is a legitimate concern among many researchers and project leaders: losing intellectual freedom, flexibility, or even the original purpose of the research.

Intelligent structuring, on the contrary, acts as a protective factor.
It makes the project more understandable, more shareable, and more credible — without altering its substance.

This balance is precisely what defines the House of BioHealth’s approach: helping establish a framework solid enough to secure the next steps, while respecting the project’s pace and identity.

Accelerating is not an obligation; it is a choice

Not all projects are meant to accelerate at the same pace. Some need time to consolidate a proof of concept, refine a use case, strengthen a team, or test a working environment.

In a sector as regulated and sensitive as healthcare, timing is often more valuable than speed. Accelerating too early can weaken a project and expose it to pressures it is not yet equipped to handle.

Conversely, accelerating at the right time — with a clear framework, appropriate resources, and a credible environment — allows for a smoother and more sustainable transition to the next phase.

Getting support without losing control

Receiving support during this phase does not mean delegating decision-making. It means benefiting from an external perspective, collective experience, and a structured environment that helps put decisions into perspective.

The House of BioHealth acts here as a support system, never as a pilot. It helps projects ask the right questions, anticipate transitions, and create the conditions for controlled acceleration.

Because in health innovation, moving fast only makes sense if you know exactly where you’re going.